300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Construction
Retail
Oil and Gas
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Art
Android
Proptech
Impact
Sustainability
Hardware
Real Estate
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Sporting Goods
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
LATAM
Oman
Poland
Puerto Rico
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Europe
Azerbaijan
Bulgaria
Qatar
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Angola
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Cyprus
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 15 Life Science Startup Investors in Hong Kong (October 2026)

The most active venture capital funds and angel investors investing in Hong Kong Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Hong Kong Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Alibaba Entrepreneurs Fund
VC Fund
2 Hong Kong, Taiwan, United States Series A, Seed, Series B Software, E-Commerce, Artificial Intelligence $510k–$150M
Gobi Partners
VC Fund
2 China, Hong Kong, Malaysia Venture - Series Unknown, Series A, Seed E-Commerce, Financial Services, Software $450k–$100M
Biokin Pharmaceutical
VC Fund
1 Hong Kong Series A Genetics, Oncology, Life Science
HitGen
VC Fund
1 Hong Kong Series A Genetics, Oncology, Life Science
Lilly Asia Ventures
VC Fund
1 China, United States, Hong Kong Series A, Series B, Series C Biotechnology, Health Care, Medical $14M–$308M
Prox Ventures
VC Fund
1 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $2.5M–$30M
Tiger Jade Capital
VC Fund
1 Hong Kong, United States Series A, Series B, Venture - Series Unknown Biotechnology, Oncology, Biopharma
Proxima Ventures Ltd
VC Fund
1 China, United States, Israel Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $223k–$150M
Hillhouse Investment
VC Fund
1 China, United States, Singapore Series B, Series A, Series C Biotechnology, Health Care, Software $2.9M–$230M
AEF Greater Bay Area Fund
VC Fund
1 Hong Kong, China, Macao Series A, Seed, Series B Artificial Intelligence, Life Science, Biotechnology $2.5M–$28M
Alon Capital Ltd
VC Fund
1 Hong Kong Series A, Series B Biopharma, Life Science, Biotechnology
Hillhouse Ventures
VC Fund
1 China, Singapore, Norway Series A, Series B, Seed Manufacturing, Biotechnology, Health Care $10M–$120M
ASBV
VC Fund
1 China, Australia, Hong Kong Seed, Series A, Angel Health Care, Medical, Biotechnology $471k–$34M
Vectr
VC Fund
1 United States, Hong Kong, Singapore Seed, Series A, Series B FinTech, Financial Services, Artificial Intelligence $547k–$70M
FutureX Capital
VC Fund
1 China, United States, Hong Kong Seed, Series A, Series B Artificial Intelligence, Manufacturing, Health Care $1.5M–$107M
Access all 21 investors in Hong Kong Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Alibaba Entrepreneurs Fund
VC Fund · Causeway Bay, Hong Kong Island, Hong Kong · 2 investments in Hong Kong Life Science startups

The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: Hong Kong, Taiwan, United States

Investor stats

  • Total investments: 81
  • Round size: Seed $510k–$8M; Series A $2M–$15M; Series B $7M–$150M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $130M in 2015

Portfolio highlights

  • Tiiny AI — Tiiny AI offers a ready-to-use open-source ecosystem with one-click installation for models.
  • Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
  • Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
Show all investments...

Gobi Partners
VC Fund · Kuala Lumpur, Kuala Lumpur, Malaysia · 2 investments in Hong Kong Life Science startups

Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Software
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: China, Hong Kong, Malaysia

Investor stats

  • Total investments: 425
  • Round size: Seed $450k–$8M; Series A $1.7M–$19M; Venture - Series Unknown $1.1M–$100M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $1.3B in 2023

Portfolio highlights

  • Yuan Planet — Youdi is a second-hand auto parts trading platform.
  • Camera360 — Camera360 is a professional but easy-to use App for photo editing and selfie retouching. Tag #camera360
  • nanoSkunkWorkx — nanoSkunkWorkX develops nanotechnology for AGI scaling and allergy biosensing.
Show all investments...

Biokin Pharmaceutical
VC Fund · Chengdu, Sichuan, China · 1 investments in Hong Kong Life Science startups

Biokin Pharmaceutical integrates drug research and development, production, and marketing. They offer a frontier field of global biomedicine, based on solving unmet clinical needs, with the ability to research and develop a full range of drugs, including small molecule chemical drugs, macromolecular biological drugs, and ADC drugs.

Show more...

Investment focus

  • Industry: Genetics, Oncology, Life Science
  • Stage:Series A
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Connexus Therapeutics — Connexus Therapeutics is a private, venture-backed biotechnology startup.
Show all investments...

HitGen
VC Fund · Chengdu, Sichuan, China · 1 investments in Hong Kong Life Science startups

HitGen is provides biological reagents and services to support drug discovery research.

Show more...

Investment focus

  • Industry: Genetics, Oncology, Life Science
  • Stage:Series A
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Connexus Therapeutics — Connexus Therapeutics is a private, venture-backed biotechnology startup.
Show all investments...

Lilly Asia Ventures
VC Fund · Shanghai, Shanghai, China · 1 investments in Hong Kong Life Science startups

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 253
  • Round size: Series A $14M–$100M; Series B $25M–$110M; Series C $30M–$308M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
  • NeuShen Therapeutics — We are a global biotech company committed to developing new and effective therapies for psychiatric and neurological disorders affecting millions of patients in need.
  • Connexus Therapeutics — Connexus Therapeutics is a private, venture-backed biotechnology startup.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 1 investments in Hong Kong Life Science startups, 6 in the past 12 months

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 83
  • Round size: Seed $2.5M–$30M; Series A $3M–$28M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • BCI-Sonics — BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications.
  • Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
  • Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Show all investments...

Tiger Jade Capital
VC Fund · Central and Western, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Life Science startups

Tiger Jade Capital is a Private Equity fund focused on global healthcare industry. It is a comprehensive healthcare fund covering new drugs, CRO, medical equipment, etc.

Show more...

Investment focus

  • Industry: Biotechnology, Oncology, Biopharma
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Hong Kong, United States

Investor stats

  • Total investments: 3
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
  • Spot Biosystems — Spot Biosystems, a life sciences company, develops new modalities of EV gene therapy
Show all investments...

Proxima Ventures Ltd
VC Fund · Tel Aviv, Tel Aviv, Israel · 1 investments in Hong Kong Life Science startups

Proxima Ventures is focused on the management of investment portfolios for its customers. It offers them with financial products and consulting services. Proxima Ventures was acquired by Soluto in October 2013. Proxima Ventures was founded by Chaim Venezia and Uri Ra'anan and is based in Tel Aviv, Israel.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Israel

Investor stats

  • Total investments: 20
  • Round size: Seed $750k–$4.5M; Series A $223k–$10M; Series B $10M–$150M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • Yidianling — Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.
  • Immune-Onc Therapeutics — Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
Show all investments...

Hillhouse Investment
VC Fund · Changyang, Beijing, China · 1 investments in Hong Kong Life Science startups

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 331
  • Round size: Series A $2.9M–$165M; Series B $15M–$230M; Series C $15M–$220M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — raised $11B in 2018

Portfolio highlights

  • Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
  • Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
  • NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Show all investments...

AEF Greater Bay Area Fund
VC Fund · Beijing, Beijing, China · 1 investments in Hong Kong Life Science startups

Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Life Science, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Hong Kong, China, Macao

Investor stats

  • Total investments: 15
  • Round size: Seed $2.5M–$5.1M; Series A $7M–$19M; Series B $14M–$28M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • SleekFlow — SleekFlow makes customer messaging apps such as WhatsApp and Facebook connected to one platform for teams to better support and engage customers.
  • Sandwich — Sandwich is an online platform that provides real-time trend analysis tools for developing ad campaigns and creating Meta Ads plans.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Alon Capital Ltd
VC Fund · Rosh Ha'ayin, HaMerkaz, Israel · 1 investments in Hong Kong Life Science startups

Make the right startup move by using our startup tools, guides, calculators and templates. Learn from other successful entrepreneurs by reading our case studies

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Series A, Series B
  • Geography: Hong Kong

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Show all investments...

Hillhouse Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Hong Kong Life Science startups

Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: China, Singapore, Norway

Investor stats

  • Total investments: 77
  • Round size: Seed $10M–$120M; Series A $10M–$85M; Series B $14M–$99M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Yatsen Holding — Yasten provides high-quality fashion makeup products.
  • kaye technology — Kaye Technology is a company that provides automation upgrade solutions for beverage equipment.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Show all investments...

ASBV
VC Fund · Shenzhen, Guangdong, China · 1 investments in Hong Kong Life Science startups

ASBV focuses on early and mid-term venture capital investments.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: China, Australia, Hong Kong

Investor stats

  • Total investments: 28
  • Round size: Seed $3M–$14M; Angel $471k–$485k; Series A $1.4M–$34M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
  • Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
  • Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Show all investments...

Vectr
VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Life Science startups

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Hong Kong, Singapore

Investor stats

  • Total investments: 81
  • Round size: Seed $547k–$6.5M; Series A $1M–$37M; Series B $12M–$70M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
  • Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
  • MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Show all investments...

FutureX Capital
VC Fund · Central, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Life Science startups, 12 in the past 12 months

FutureX Capital is an investment firm.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Manufacturing, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 42
  • Round size: Seed $1.5M–$14M; Series A $10M–$43M; Series B $31M–$107M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Kaiwang Data — Kaiwang Data is a one-stop shop for data solutions. It focuses on offering complete data labeling solutions for automakers and businesses involved in autonomous driving.
  • Wanjuan Intelligent — Wanjuan Intelligence is an enterprise-level work platform driven by Engineer Agents. Its objective is to shift the work paradigm from human + hardware/software to human + Agents.
  • Xili Optoelectronics — Xili Optoelectronics is a pioneering company focused on the development of advanced, future-oriented optical engine system integrated chips (OE-SICs) that deliver high bandwidth and low energy consumption.
Show all investments...

Life Science Investor funding in Hong Kong at a glance

Stats across 9 deals from 21 investors.

21
investors
in Hong Kong Life Science startups
9
deals
in Hong Kong Life Science startups
$13M
median round
in Hong Kong Life Science startups
33%
lead investors
lead at least one round
33%
Series A
most common funding stage
100/0
VC / Angel
share of investor count

Access all 21 investors in Hong Kong Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in Hong Kong investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 21 investors investing in Hong Kong Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists